BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 14561161)

  • 21. The in vitro anti-inflammatory effects of recombinant anti-CD25 immunotoxin on lamina propria T cells of patients with inflammatory bowel disease are not sufficient to cure experimental colitis in mice.
    Pfister K; Wittig BM; Jüngling B; Ecker KW; Barth S; Huhn M; Sasse S; Engert A; Mueller-Molaian I; Diehl V; Zeitz M; Stallmach A
    Int J Colorectal Dis; 2002 Mar; 17(2):77-84. PubMed ID: 12014425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental colitis models: Insights into the pathogenesis of inflammatory bowel disease and translational issues.
    Valatas V; Bamias G; Kolios G
    Eur J Pharmacol; 2015 Jul; 759():253-64. PubMed ID: 25814256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biologic therapy for inflammatory bowel disease.
    Ardizzone S; Bianchi Porro G
    Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human Intestinal Dendritic Cells in Inflammatory Bowel Diseases.
    Bernardo D; Chaparro M; Gisbert JP
    Mol Nutr Food Res; 2018 Apr; 62(7):e1700931. PubMed ID: 29336524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signal transducers and activators of transcription 3 signaling pathway: an essential mediator of inflammatory bowel disease and other forms of intestinal inflammation.
    Musso A; Dentelli P; Carlino A; Chiusa L; Repici A; Sturm A; Fiocchi C; Rizzetto M; Pegoraro L; Sategna-Guidetti C; Brizzi MF
    Inflamm Bowel Dis; 2005 Feb; 11(2):91-8. PubMed ID: 15677901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases.
    Bouguen G; Chevaux JB; Peyrin-Biroulet L
    World J Gastroenterol; 2011 Feb; 17(5):547-56. PubMed ID: 21350703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Etiology and pathogenesis of inflammatory bowel disease.
    Schmidt C; Stallmach A
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):127-45. PubMed ID: 15990703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The immuno-inflammatory mechanism for tissue injury in inflammatory bowel disease and Helicobacter pylori-infected chronic active gastritis. Roles of the mucosal immune system.
    Nagura H; Ohtani H; Sasano H; Matsumoto T
    Digestion; 2001; 63 Suppl 1():12-21. PubMed ID: 11173904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
    Szewczuk MR; Depew WT
    Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokines in inflammatory bowel diseases - Update 2020.
    Leppkes M; Neurath MF
    Pharmacol Res; 2020 Aug; 158():104835. PubMed ID: 32416212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endomicroscopy and Molecular Tools to Evaluate Inflammatory Bowel Disease.
    Buchner AM; Wallace MB
    Gastrointest Endosc Clin N Am; 2016 Oct; 26(4):657-68. PubMed ID: 27633594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic review: histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative.
    Bryant RV; Winer S; Travis SP; Riddell RH
    J Crohns Colitis; 2014 Dec; 8(12):1582-97. PubMed ID: 25267173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis.
    Eichele DD; Kharbanda KK
    World J Gastroenterol; 2017 Sep; 23(33):6016-6029. PubMed ID: 28970718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Nitric oxide and inflammatory bowel disease].
    García-González MA; Peña AS
    Rev Esp Enferm Dig; 1998 Dec; 90(12):870-6. PubMed ID: 9973849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis.
    Terc J; Hansen A; Alston L; Hirota SA
    Eur J Pharm Sci; 2014 May; 55():12-9. PubMed ID: 24486481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
    Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
    Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of mucosal dendritic cells in inflammatory bowel disease.
    Niess JH
    World J Gastroenterol; 2008 Sep; 14(33):5138-48. PubMed ID: 18777590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment with Bifidobacterium bifidum 17 partially protects mice from Th1-driven inflammation in a chemically induced model of colitis.
    Philippe D; Heupel E; Blum-Sperisen S; Riedel CU
    Int J Food Microbiol; 2011 Sep; 149(1):45-9. PubMed ID: 21257218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Epithelial cell in intestinal homeostasis and inflammatory bowel diseases].
    Zouiten-Mekki L; Serghini M; Fekih M; Kallel L; Matri S; Ben Mustapha N; Boubaker J; Filali A
    Med Sci (Paris); 2013 Dec; 29(12):1145-50. PubMed ID: 24356146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe inflammatory bowel disease: medical management.
    Farthing MJ
    Dig Dis; 2003; 21(1):46-53. PubMed ID: 12838000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.